Source link : https://www.newshealth.biz/health-news/next-in-class-once-daily-pill-approved-for-cystic-fibrosis/
The FDA approved a once-daily oral combination of vanzacaftor/tezacaftor/deutivacaftor (Alyftrek) for cystic fibrosis (CF) in adults and children 6 years and up, drugmaker Vertex Pharmaceuticals announced on Friday. Eligible patients must have at least one mutation in F508del or another responsive mutation in the CFTR gene. Of note, the CFTR modulator carries a boxed warning […]
Author : News Health
Publish date : 2024-12-20 22:44:47
Copyright for syndicated content belongs to the linked Source.
inHealth